| Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia FM Leweke, D Piomelli, F Pahlisch, D Muhl, CW Gerth, C Hoyer, ... Translational psychiatry 2 (3), e94-e94, 2012 | 1282 | 2012 |
| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 1052 | 2017 |
| Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms A Giuffrida, FM Leweke, CW Gerth, D Schreiber, D Koethe, J Faulhaber, ... Neuropsychopharmacology 29 (11), 2108-2114, 2004 | 618 | 2004 |
| Elevated endogenous cannabinoids in schizophrenia FM Leweke, A Giuffrida, U Wurster, HM Emrich, D Piomelli Neuroreport 10 (8), 1665-1669, 1999 | 590 | 1999 |
| Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia E Holmes, TM Tsang, JTJ Huang, FM Leweke, D Koethe, CW Gerth, ... PLoS medicine 3 (8), e327, 2006 | 342 | 2006 |
| Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system HM Emrich, FM Leweke, U Schneider Pharmacology Biochemistry and Behavior 56 (4), 803-807, 1997 | 312 | 1997 |
| Antibodies to infectious agents in individuals with recent onset schizophrenia FM Leweke, CW Gerth, D Koethe, J Klosterkötter, I Ruslanova, ... European archives of psychiatry and clinical neuroscience 254, 4-8, 2004 | 295 | 2004 |
| Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use FM Leweke, A Giuffrida, D Koethe, D Schreiber, BM Nolden, L Kranaster, ... Schizophrenia research 94 (1-3), 29-36, 2007 | 292 | 2007 |
| Cannabis and psychiatric disorders: it is not only addiction FM Leweke, D Koethe Addiction biology 13 (2), 264-275, 2008 | 291 | 2008 |
| Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations European Network of National Networks studying Gene-Environment Interactions ... Schizophrenia bulletin 40 (4), 729-736, 2014 | 280 | 2014 |
| Identification of a biological signature for schizophrenia in serum E Schwarz, PC Guest, H Rahmoune, LW Harris, L Wang, FM Leweke, ... Molecular psychiatry 17 (5), 494-502, 2012 | 278 | 2012 |
| Cannabis use and psychosis: a review of reviews A Hasan, R von Keller, CM Friemel, W Hall, M Schneider, D Koethe, ... European archives of psychiatry and clinical neuroscience 270, 403-412, 2020 | 269 | 2020 |
| Gastrointestinal inflammation and associated immune activation in schizophrenia EG Severance, A Alaedini, S Yang, M Halling, KL Gressitt, CR Stallings, ... Schizophrenia research 138 (1), 48-53, 2012 | 265 | 2012 |
| Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia EG Severance, KL Gressitt, CR Stallings, AE Origoni, S Khushalani, ... Schizophrenia research 148 (1-3), 130-137, 2013 | 264 | 2013 |
| PRECLINICAL STUDY: acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats M Schneider, E Schömig, FM Leweke Addiction biology 13 (3‐4), 345-357, 2008 | 239 | 2008 |
| High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides E Schwarz, S Prabakaran, P Whitfield, H Major, FM Leweke, D Koethe, ... Journal of proteome research 7 (10), 4266-4277, 2008 | 233 | 2008 |
| Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression D Koethe, IC Llenos, JR Dulay, C Hoyer, EF Torrey, FM Leweke, S Weis Journal of neural transmission 114, 1055-1063, 2007 | 233 | 2007 |
| Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis D Koethe, A Giuffrida, D Schreiber, M Hellmich, F Schultze-Lutter, ... The British Journal of Psychiatry 194 (4), 371-372, 2009 | 229 | 2009 |
| Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis JTJ Huang, FM Leweke, D Oxley, L Wang, N Harris, D Koethe, CW Gerth, ... PLoS medicine 3 (11), e428, 2006 | 220 | 2006 |
| Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia E Schwarz, R Izmailov, M Spain, A Barnes, JP Mapes, PC Guest, ... Biomarker insights 5, BMI. S4877, 2010 | 217 | 2010 |
Cathrin RohlederVerified email at cimh.de
